NDC 10135-747

Digoxin 0.125 mg tablet

On the label: Marlex Pharmaceuticals, Inc.. It's a repackaged product: Marlex Pharmaceuticals, Inc. rebottles it from ANI Pharmaceuticals, Inc.'s NDC 70954-201.

Where the pills inside were made

Novitium Pharma LLC

East Windsor, NJ, United States · makes it, tests it, packages it and labels it

No problems found Last FDA inspection Feb 16, 2024. 5 inspections on record.

Recalls

• Mar 25, 2024 · Class III · Terminated
  Failed Impurities/Degradation Specifications
  Lots: Lot M23011A; Exp. 12/2024
• Mar 4, 2024 · Class III · Terminated
  Cross Contamination with Other Products:(mycophenolate mofetil).
  Lots: Lot #: M23172A, Exp 01/31/2025

Product details

Generic drug

Digoxin: see every company that makes it

Form

tablet, oral

Strength

0.125 mg

Approval

ANDA ANDA215307

On the market since

Jun 1, 2022

Package NDCs

10135-747-01 10135-747-10

Official label

DailyMed (National Library of Medicine), updated Oct 8, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?